#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paraneoplastic neurological syndrome ABO haemolytic disease of newborn Neuroendocrine carcinoma Ovarian cancer stage IV Cutaneous calcification Osteosarcoma metastatic Pneumonia Neurofibromatosis Fusarium infection Glioma Intracranial germ cell tumour T-cell type acute leukaemia Congenital nephrogenic diabetes insipidus Chronic graft versus host disease in liver Cardiomyopathy More trials…

    Learn about Rare Diseases

    Nephroblastoma Rett syndrome – Trials in Disease Progressive supranuclear palsy – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Marfan’s syndrome – Life with Disease Mitochondrial myopathy – Diagnostics Sarcoidosis Shprintzen-Goldberg syndrome – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) Marginal zone lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tipapkinogene Sovacivec Haloperidol Colistimethate Sodium Iron IDP-121 Capmatinib Abacavir Sulfate Iloprost Trometamol Liquid Paraffin SKB410 Propafenone Hydrochloride Sodium Hyaluronate Sym025 Mps-112 Tolinapant Lactate Quercus Ilex Allergen Extract Hydrocortisone Ioflupane (123I) Incb099280 MAPLIRPACEPT More therapies…

    Learn about Your Condition

    Oropharyngeal cancer recurrent Pelizaeus-Merzbacher disease Urticaria cholinergic Breast cancer stage III Ependymoma Back pain Oedema Lung adenocarcinoma Neonatal hyperglycaemia Sinus rhythm Chondrosarcoma Bipolar I disorder Liver transplant Prostatitis Escherichia coli Myofascial pain syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

End stage renal disease

  • Study of Patiromer to Allow Less Dietary Potassium Restrictions in Patients on Chronic Dialysis with Controlled Blood Potassium Levels

    Recruiting

    3 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Patiromer
    Italy

  • Reduced Immunosuppression Therapy Trial for Elderly Kidney Transplant Recipients with End-Stage Renal Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Basiliximab
    • Mycophenolate Sodium
    • Lidocaine Hydrochloride Monohydrate
    Spain

  • Study on the Safety and Effectiveness of PolyCore (Xylitol, L-Carnitine, Polydextrin) for Patients with End-Stage Kidney Disease Starting Peritoneal Dialysis

    Recruiting

    2 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Lactic Acid
    • Levocarnitine
    • Polydextrose
    Italy

  • Study on Mannitol and Normal Saline for Patients with End-Stage Renal Disease Undergoing Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Renal transplant
    Investigated Drugs:
    • Mannitol
    Finland

  • Study on Alkaline Phosphatase for Reducing Kidney Transplant Complications in Patients with End-Stage Kidney Disease

    Recruiting

    2 1
    Investigated Diseases:
    • End stage renal disease
    • Reperfusion injury
    Investigated Drugs:
    • Alkaline Phosphatase, Bovine
    The Netherlands

  • Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Glucose Monohydrate Ph. Eur.
    • Levocarnitine
    • Sodium S-Lactate Solution
    Denmark Germany Italy Spain Sweden
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!